<DOC>
	<DOCNO>NCT02217553</DOCNO>
	<brief_summary>Platelets play pivotal role atherosclerosis acute cardiovascular event . Platelet hyperreactivity increase platelet-monocyte aggregate ( PMA ) formation find HIV infected patient , may contribute excess cardiovascular risk . Low level vitamin D associate presence cardiovascular disease . The aim study determine effect vitamin D supplementation platelet activation , platelet reactivity platelet-leukocyte complex formation asymptomatic HIV-infected patient treat ART</brief_summary>
	<brief_title>The Effect Vitamin D Supplementation HIV-associated Platelet Hyperreactivity</brief_title>
	<detailed_description>1 . Study design A prospective intervention study . HIV-infected patient use ART come follow-up Teratai HIV clinic ask participate study . All study participant receive vitamin D supplementation ( soft gel capsule contain cholecalciferol 400 IU ) consume 2 soft gel capsule daily three consecutive month . The effect platelet parameter specify determined start cholecalciferol supplementation three month . 2 . Duration study Usually , 150 HIV-infected patient treat ART every week Teratai HIV clinic Hasan Sadikin Hospital Bandung Indonesia . Between half January 2014 end February 2014 , 50 patient enrol study . We hypothesize period long enough include 50 patient present study . Supplementation take place March May analysis do June July . A summary duration study depict study timeline . 3 . Study population The study population consist adult HIV-infected patient treat ART enrol HIV polyclinic Hasan Sadikin General Hospital , Bandung , Indonesia . 4 . Sample size calculation Our sample size calculation base primary outcome , area curve ( AUC ) platelet reactivity curve P-selectin ( CD62P ) platelet activation marker ADP platelet agonist . In cohort Dutch HIV-infected patient find mean AUC 2500 SD 660 . Assuming decrease AUC 2500 2100 upon supplementation vitamin D clinically relevant , sample size 23 would sufficient use paired design α 0.05 power 80 % . 5 . Methods Study parameters/endpoints There two study parameter apply study : 1 . Platelet reactivity , express membrane expression platelet activation marker CD62P ( P-selectin ) fibrinogen bind integrin αIIbβ3 , stimulation increase concentration platelet agonists ADP . 2 . Platelet-monocyte complex . 6 . Study procedure a. Enrolment patient During scheduled routine polyclinic visit , treat internist identify patient fulfil inclusion criterion . He/she explain background objective study patient . In case patient opt participate , patient ask read undersign inform consent form . Venous blood ( three tube 3 mL ) drawn study purpose enrolment three month supplementation : 1 . 25-hydroxyvitamin D level ( 3 ml serum ) 2 . Platelet assay specify ( 3 ml CTAD ) 3 . Full blood count CD4 cell ( 3 ml EDTA ) In many instance , require extra venepuncture blood usually collect planned blood analysis routine clinical care regular polyclinic visit . Measurements analysis consist 25-hydroxyvitamin D level , platelet reactivity , platelet-monocyte complex do patient participate study . The study participant receive 180 soft gel cholecalciferol capsule , take 2 capsule day 90 day state . As state , second blood analysis take place three month later vitamin D supplementation complete . b . Collection blood sample vitamin D level analysis As much 3mL additional blood withdrawn apply venepuncture routine CD4+ measurement . Collected blood store use red top serum tube without anticoagulant . This take place enrolment ( day 0 ) 3 month vitamin D supplementation . Each day blood withdrawal , collect tube store temporarily wet-iced box prior transfer laboratory vitamin D analysis . At end policlinic day , tubes transfer laboratory serum separation . Then , separate serum store 25-hydroxyvitamin D measurement do later . All sample analyse 25-hydroxyvitamin D measurement well vitamin D metabolite free 25-hydroxyvitamin D measurement . Such analysis do Indonesia therefore sample ship Netherlands purpose . c. Collection blood sample platelet function analysis As specify study parameter , platelet function analysis perform one 3mL citrate-anticoagulated blood tube . This take place enrolment ( day 0 ) 3 month vitamin D supplementation . Each withdrawn blood patient , tube directly transfer laboratory platelet function within 30 minute . d. Full blood count CD4 cell measurement These measurement part routine care do routine haematological laboratory use 3 ml EDTA blood .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Blood Platelet Disorders</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>&gt; 18 year Treated suppressive firstline ART least 12 month Compliant ART procedures Teratai clinic No sign symptom Use aspirin platelet function inhibitor . Any sign symptom Known active opportunistic infection Active illicit drug user comorbidity History fail ART noncompliance . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>platelet</keyword>
	<keyword>P-selectin</keyword>
	<keyword>platelet-fibrinogen binding</keyword>
	<keyword>platelet-monocye aggregate formation</keyword>
	<keyword>vitamin D</keyword>
</DOC>